These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22689897)

  • 1. Anticounterfeiting agreement will hinder trade in generic drugs, protesters say.
    Limb M
    BMJ; 2012 Jun; 344():e4073. PubMed ID: 22689897
    [No Abstract]   [Full Text] [Related]  

  • 2. Defeat of antipiracy treaty is hailed as victory for generic drugs.
    Moszynski P
    BMJ; 2012 Jul; 345():e4660. PubMed ID: 22777031
    [No Abstract]   [Full Text] [Related]  

  • 3. A trade agreement's impact on access to generic drugs.
    Shaffer ER; Brenner JE
    Health Aff (Millwood); 2009; 28(5):w957-68. PubMed ID: 19706626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAFTA will harm HIV care, according to critics. Final agreement helps drug companies, they say.
    AIDS Alert; 2004 Feb; 19(2):17-8. PubMed ID: 15011625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Academics should use their intellectual property to produce cheap drugs for poor countries.
    Watts G
    BMJ; 2007 May; 334(7603):1079. PubMed ID: 17525425
    [No Abstract]   [Full Text] [Related]  

  • 6. Elixirs of death. International organizations are working towards a global solution to address the problem of falsified and substandard medicines, but progress has stagnated.
    Weigmann K
    EMBO Rep; 2013 Jul; 14(7):597-600. PubMed ID: 23764922
    [No Abstract]   [Full Text] [Related]  

  • 7. Trade agreements, intellectual property, and the role of the World Bank in improving access to medicines in developing countries.
    Rovira J
    Yale J Health Policy Law Ethics; 2004; 4(2):401-13. PubMed ID: 15536921
    [No Abstract]   [Full Text] [Related]  

  • 8. Governments pledge to clamp down on counterfeit drugs.
    Watson R
    BMJ; 2011 Nov; 343():d7096. PubMed ID: 22045993
    [No Abstract]   [Full Text] [Related]  

  • 9. Intellectual property protection for plant-related inventions in Europe.
    Fleck B; Baldock C
    Nat Rev Genet; 2003 Oct; 4(10):834-8. PubMed ID: 14526379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards.
    Cohen-Kohler JC; Forman L; Lipkus N
    Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A one-time-only combination: Emergency medicine exports and the TRIPS agreement under Canada's access to medicines regime.
    Weber A; Mills L
    Health Hum Rights; 2010 Jun; 12(1):109-22. PubMed ID: 20930258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. India-EU free trade agreement threatens access to generic drugs, MSF warns.
    Moszynski P
    BMJ; 2010 Apr; 340():c2309. PubMed ID: 20423974
    [No Abstract]   [Full Text] [Related]  

  • 13. Production of low cost AIDS drugs to continue in Brazil.
    Reprod Health Matters; 2001 Nov; 9(18):178. PubMed ID: 11803899
    [No Abstract]   [Full Text] [Related]  

  • 14. Health priorities gain patent reprieve for developing countries.
    Cherry M
    Nature; 2001 Nov; 414(6862):385. PubMed ID: 11719767
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxfam India mounts campaign to protect affordable drugs.
    Mayor S
    BMJ; 2014 Dec; 349():g7568. PubMed ID: 25491483
    [No Abstract]   [Full Text] [Related]  

  • 16. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
    Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
    AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
    [No Abstract]   [Full Text] [Related]  

  • 17. India-EU free-trade pact could stifle generics industry.
    Chatterjee P
    Lancet; 2011 Apr; 377(9774):1305-6. PubMed ID: 21504087
    [No Abstract]   [Full Text] [Related]  

  • 18. Indian generic drug production. Benefits of EU-India free trade agreement.
    Ager B
    BMJ; 2011 Apr; 342():d2439. PubMed ID: 21502277
    [No Abstract]   [Full Text] [Related]  

  • 19. Implications of bilateral free trade agreements on access to medicines.
    Correa CM
    Bull World Health Organ; 2006 May; 84(5):399-404. PubMed ID: 16710551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IP litigation in China could drive innovation.
    Jia H
    Nat Biotechnol; 2004 Apr; 22(4):368. PubMed ID: 15060539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.